Skip to main content
HERBALIFE LTD. logo

HERBALIFE LTD. — Investor Relations & Filings

Ticker · HLF ISIN · USG4412G1016 LEI · 549300BA7TYPBSZZIA41 US Manufacturing
Open in API
Filings indexed 1,645 across all filing types
Latest filing 2015-05-11 Regulatory Filings
Country KY Cayman Islands
Listing US HLF

About HERBALIFE LTD.

https://www.herbalife.com/

Herbalife Ltd. is a global company that develops and sells a range of health and wellness products. Its portfolio is categorized into weight management, targeted nutrition, energy and fitness, and outer nutrition. Key offerings include meal replacement protein shakes, dietary supplements, protein powders, and personal care items. The company utilizes a direct-selling model, distributing its products through a network of independent distributors. These distributors also provide personalized coaching and community support to customers, encouraging the adoption of a healthier, more active lifestyle in conjunction with product use.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2015
Regulatory Filings
2015-05-11 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions the closing of the third amendment of an existing syndicated credit agreement and includes a press release as an exhibit. This indicates the document is an update on financing activities. The document length is 2376 characters, which is relatively short and focused on a specific event rather than a full financial report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2015-05-06 English
HERBALIFE LTD. 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 5, 2015, by Herbalife Ltd. It specifically references Item 2.02, which pertains to "Results of Operations and Financial Condition." The text states that Herbalife issued a press release announcing its financial results for the fiscal quarter ended March 31, 2015, and that the press release is attached as Exhibit 99.1. The document itself is a current report filing that includes the press release but does not contain detailed financial statements or comprehensive financial analysis. The length of the document is 2966 characters, which is relatively short and consistent with a press release or earnings announcement rather than a full quarterly or annual report. According to the filing definitions, an initial announcement of quarterly financial results (key highlights only) corresponds to an Earnings Release (ER). Therefore, this document should be classified as an Earnings Release (ER).
2015-05-05 English
10-Q
Interim / Quarterly Report Q1 2015
2015-05-05 English
FORM 3 SUBMISSION
Director's Dealing
2015-05-04 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a detailed correspondence letter from Herbalife Ltd. to the SEC responding to a comment letter regarding their Form 10-K for the fiscal year ended December 31, 2014, and other filings. It discusses specific disclosures in the 10-K, proposed revisions to disclosures, and plans to include expanded disclosures in future filings such as the Quarterly Report on Form 10-Q. The content is focused on clarifying and amending disclosures related to the 10-K and future quarterly reports, but it is not the 10-K report itself. The document is a regulatory correspondence and response to SEC comments, not a full financial report or earnings release. It is also not a certification letter or a brief announcement. Given the nature of the document as a detailed regulatory correspondence responding to SEC comments on filings, the appropriate classification is Regulatory Filings (RNS).
2015-05-01 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.